A new survey from Mashable finds nearly 10 percent of Americans admit to smoking pot before heading into the office. CNBC's Kate Rogers shares the difficulties in testing employees.» Read More
The relative prospects for shares of Pfizer and Johnson & Johnson are debated by a fundamental analyst and a technical analyst. (2:58)
In the wake of Johnson & Johnson's manufacturing problems, CVS has changed the way it stocks Tylenol, reports CNBC's Bertha Coombs.
NBC's Anne Thompson reports Lance Armstrong confessed to using performance enhancing drugs in an interview with Oprah Winfrey; and CNBC's Scott Cohn reports Armstrong has now complied with the subpoena for all of his medical records.
Could a widely used MS treatment work on other diseases?
The iShare Biotech ETF is up 32 percent over the past year. Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO, discusses the reason behind his company behind up 24.9 percent in the last 3 months.
Retailers should be buzzing right now with holiday gift card redemptions. But, there's early evidence retailers aren't getting much of a boost from gift cards this year, according to NBG Market Analyst Brian Sozzi.
Onyx Pharmaceuticals CEO Dr. Anthony Coles discusses his company's thyroid cancer drug and its blood cancer drug and its partnership with Bayer.
NPS Pharmaceuticals CEO Dr. Francois Nader discusses the approval of its short bowel syndrome drug Gattex, and what's next for the company.
The latest batch of retail sales reports shed light on who the retail winners are right now.
The American Psychiatric Association now says it's okay to use antidepressants for someone who is grieving over a recently lost loved one. Beverly Hills Psychiatrist Dr. Carole Lieberman, offers insight.
The Supreme Court is taking on the "pay for delay" method used by big pharmaceutical companies, and pilots at American Airlines voted to ratify a new contract, reports CNBC's Brian Shactman.
CNBC's Jane Wells reports Washington's new state law that makes it legal to smoke pot, is more complicated than it sounds, and Allen St. Pierre, NORML executive director, weighs in on the financial benefits of reforming marijuana laws.
Some 150 workers at TriHealth, a Cincinnati-based health care company are unemployed today because they refused to get a free, company-sponsored flu shot. Michael Cannon, Cato Institute, thinks the company has a right to make this decision, while Barbara Fisher, National Vaccine Information Center, thinks this a violation of the workers' informed consent rights.
Colorado and Washington made history on Tuesday becoming the first states to legalize the recreational use of marijuana. Janine Turner, Constituting America founder & co-chair, says "this is really disappointing, and stealing the promise of the future of America."
A new study out today in The New England Journal of Medicine finds statin use reduces the risk of death from cancer. Dr. Lori Mosca of New York Presbyterian Hospital and Columbia University Medical Center, offers insight on the drug and its side effects.
The marijuana business is worth more than $300 billion worldwide, with CNBC's Brian Shactman & Brian Vicente, Campaign to Regulate Marijuana Like Alcohol.
NPS Pharmaceuticals president & CEO Dr. Francois Nader, discusses strategies his company uses to finding value for shareholders, and appealing to the FDA.
Why vitamin stocks are moving higher, with CNBC's Seema Mody.
NBC's Tom Costello reports on the outbreak of meningitis tied to a contaminated drug, saying as many as 13,000 people may have received one of the contaminated steroids.
Pharmaceuticals continue to be an attractive sector for earnings and dividend growth, and CNBC's Seema Mody reports on how companies like Pfizer are faring.